Français 
English 
Русский 
Español 
Deutsch 
Português 
العربية 
Italiano 
A hematology auto analyzer is a laboratory instrument that automatically counts, classifies, and analyzes blood cells from a small sample, delivering fast and accurate results that form the backbone of clinical diagnostics worldwide. From detecting infections and anemia to screening for blood disorders, these devices have fundamentally transformed how healthcare professionals interpret complete blood counts (CBC) — and today, AI-powered platforms are pushing that transformation even further.
What Is a Hematology Auto Analyzer?
A hematology auto analyzer, also called an automated hematology analyzer or CBC analyzer, is a medical diagnostic device designed to quantify and characterize the cellular components of blood. Instead of relying on time-consuming manual microscopy, these instruments process blood samples automatically, generating detailed reports within minutes.
Historically, blood cell analysis evolved through several technological generations — from basic manual microscopy in the 1850s, to impedance-based counting in the 1950s, flow cytometry in the 1970s, and now AI-driven cell morphology analysis since 2017. Each generation improved speed, accuracy, and the depth of clinical information available from a single blood draw.
Modern analyzers can measure dozens of parameters simultaneously, providing healthcare providers with a rich dataset that supports diagnosis of infections, hematological malignancies, nutritional deficiencies, and many other conditions — all from a small volume of capillary or venous blood.
How Does a Hematology Auto Analyzer Work?
Most contemporary hematology analyzers use one or more of the following analytical principles:
- Electrical impedance: Cells passing through a small aperture disrupt an electrical current; the magnitude of disruption indicates cell size and count
- Flow cytometry: Cells suspended in fluid pass single-file through a laser beam; scattered and emitted light reveals size, granularity, and surface markers
- Cell morphology imaging (CBM): High-resolution cameras capture microscopic images of stained blood cells; AI algorithms classify each cell type based on visual morphology
- Photoelectric colorimetry: Used specifically for hemoglobin (HGB) measurement using the Lambert-Beer law
The most advanced systems, such as the AI-based CBM technology developed by Ozelle, combine a 4-megapixel SwissOptic customized lens with 50 fps image capture, a fully automated mechanical arm with 1 µm repeatability positioning accuracy, and deep learning algorithms trained on over 40 million real clinical samples. This enables identification of rare cell types — including band neutrophils (NST), hypersegmented neutrophils (NSH), atypical lymphocytes (ALY), platelet aggregates (PAg), and reticulocytes (RET) — that older impedance-based methods may miss.
Key Parameters Measured
A standard CBC from a hematology auto analyzer covers white blood cells, red blood cells, and platelets. Advanced 7-differential analyzers go significantly deeper:
| Parameter Group | Examples | Clinical Relevance |
|---|---|---|
| White Blood Cells (WBC) | NEU, LYM, MON, EOS, BAS | Infection, allergy, immune response |
| Neutrophil Subtypes | NST (bands), NSG (mature), NSH (hypersegmented) | Left shift, dysplasia, megaloblastic anemia |
| Globules rouges (GR) | RBC, HGB, HCT, MCV, MCH, MCHC, RDW-SD, RDW-CV | Anemia, iron deficiency, hemolysis |
| Platelets | PLT, MPV, PDW, PCT, P-LCR, P-LCC, PAg | Thrombocytopenia, clotting disorders |
| Special Indices | NLR, PLR, ALY, RET | Immune status, bone marrow activity |
| Abnormal Cell Flags | Schistocyte, Echinocyte, Teardrop cell | Microangiopathy, liver disease, myelofibrosis |
The Ozelle EHBT-50, for example, reports 37 paramètres for a 7-diff CBC, including NST, NSG, NSH, NLR, PLR, ALY, PAg, and RET alongside standard CBC values. This level of detail was previously only available through manual peripheral blood smear review by trained pathologists.
Types of Hematology Auto Analyzers
Not all automated hematology analyzers are created equal. They differ primarily in the number of white blood cell subpopulations they differentiate:
| Type | WBC Differentiation | Meilleur pour |
|---|---|---|
| 3-Part Differential | Granulocytes, lymphocytes, mid-range cells | Basic screening, primary care, rural clinics |
| 5-Part Differential | NEU, LYM, MON, EOS, BAS | Most hospital labs and clinical settings |
| 7-Part Differential | All 5-part + NST, NSG, NSH, ALY, PAg, RET | Advanced diagnostics, specialist clinics |
| Multi-Functional All-in-One | 7-diff + immunoassay + biochemistry + urine/feces | Point-of-care, resource-limited settings |
Ozelle offers a full product range covering all these tiers. The EHBT-25 is a 3-diff analyzer ideal for compact, high-throughput primary care use with a 12 samples/hour rate. The EHBT-75 is a 7-diff standalone hematology analyzer with deep abnormal cell detection capabilities, delivering results in just 6 minutes. The flagship EHBT-50 MiniLab combines 7-diff hematology with immunoassay, biochemistry, urine, and fecal testing in a single platform weighing just 15 kg.
Explore Ozelle’s full hematology analyzer lineup at https://ozellemed.com/en/.
Applications cliniques
Hematology auto analyzers are critical tools across a wide spectrum of medical specialties:
- Infection detection: Elevated WBC, NST (band neutrophils), and inflammatory ratios like NLR and PLR indicate bacterial or viral infections
- Anemia diagnosis: Low HGB, MCV, MCH, and elevated RDW help classify iron-deficiency, megaloblastic, and hemolytic anemias
- Hematological malignancy screening: Abnormal cell counts, unusual morphology flags (schistocytes, teardrop cells), and immature granulocytes trigger specialist referrals
- Platelet disorders: Low PLT, elevated PAg (platelet aggregates), or abnormal PDW may indicate thrombocytopenia or clotting disorders
- Bone marrow assessment: NST elevation (left shift) and RET count reflect marrow stress and erythropoietic activity
- Chronic disease monitoring: Serial CBC monitoring tracks treatment response in oncology, autoimmune disease, and chronic infections
When combined with immunoassay and biochemistry panels — as supported by the Ozelle EHBT-50 — a single patient encounter can screen for thyroid dysfunction, cardiac markers, diabetes, kidney function, and inflammation markers simultaneously. This dramatically reduces cost, sample collection burden, and turnaround time, particularly in resource-limited or point-of-care settings.
AI and the Future of Hematology Analysis
Artificial intelligence is redefining what a hematology auto analyzer can do. Traditional impedance analyzers count cells based on size and electrical properties, but AI-powered cell morphology systems actually see each cell — capturing its shape, nuclear structure, cytoplasmic granularity, and staining characteristics — then classify it using convolutional neural networks (CNN) trained on massive clinical datasets.
Ozelle’s AI engine, recognized at the 2022 World Artificial Intelligence Conference (WAIC), was trained on over 40 million clinical samples and has been deployed across more than 50,000 installed units globally. The system continuously improves through Auto-ML iteration and is now integrated with a large diagnostic model (Qwen3-based) that provides AI-assisted clinical interpretation — explaining what abnormal results might mean, flagging potential diagnoses, and correlating findings across parameters.
The smart IoT platform enables centralized device management, remote data access, distributor analytics, and a patient management app — turning the analyzer from a standalone instrument into a connected diagnostic ecosystem.
Ozelle EHBT Series: Specifications at a Glance
| Modèle | Diff Type | Paramètres | Débit | Volume de l'échantillon | Dimensions |
|---|---|---|---|---|---|
| EHBT-25 | 3-Diff | 21 CBC params | 12 samples/hr | 40 µL | 360×290×400 mm |
| EHBT-75 | 7-Diff | 37+ CBC params | 10 samples/hr | 30–60 µL | 415×203×483 mm |
| EHBT-50 MiniLab | 7-Diff + Multi | 37 CBC + Immunoassay + Biochemistry | 10 samples/hr | 30 µL (CBC) | 400×350×450 mm |
All models support capillary blood (fingertip sampling), operate at room temperature, use maintenance-free individual test kits, and carry CE and FDA certifications. This makes them especially well-suited for pharmacies, GP clinics, ambulance units, emergency departments, and mobile health settings where large floor-standing lab equipment is impractical.
Advantages Over Traditional Manual Methods
| Fonctionnalité | Manual Microscopy | Traditional Impedance Analyzer | AI CBM Analyzer (e.g., Ozelle) |
|---|---|---|---|
| Speed | 30–60 min | 1–3 min | 6 min (with images) |
| Operator skill required | Haut | Faible | Minime |
| Abnormal cell detection | Expert-dependent | Limitée | Automated & AI-flagged |
| Cell morphology images | Yes (manual) | Non | Yes (AI-reviewed) |
| Parameters reported | 10–20 | 20–25 | 37+ |
| Standardization | Faible | Moyen | Haut |
| Maintenance | None (manual) | Frequent reagent/waste | Maintenance-free (kit-based) |
The shift to AI-based cell morphology analysis provides lab-grade precision without requiring a highly trained hematologist at every point-of-care site — a significant advantage for primary healthcare in developing regions.
Frequently Asked Questions (FAQs)
Q1: What is the difference between a 3-part and 7-part differential hematology analyzer?
A 3-part differential groups white blood cells into three categories: granulocytes, lymphocytes, and mid-range cells. A 7-part differential breaks these down further into NEU, LYM, MON, EOS, BAS, and adds specialized subtypes like NST (band neutrophils), NSG (segmented neutrophils), NSH (hypersegmented neutrophils), ALY (atypical lymphocytes), PAg (platelet aggregates), and RET (reticulocytes). The 7-part differential offers significantly deeper clinical insight and is better suited for detecting infections, hematological disorders, and bone marrow abnormalities.
Q2: How much blood does a hematology auto analyzer need?
Modern point-of-care analyzers like the Ozelle EHBT-50 require as little as 30 µL of capillary blood — roughly one drop from a fingertip. This makes testing accessible for infants, elderly patients, and individuals with difficult venous access.
Q3: How long does it take to get results from a hematology auto analyzer?
AI-powered analyzers like the Ozelle EHBT-75 and EHBT-50 deliver complete CBC results with morphology images in approximately 6 minutes per sample.
Q4: Can a hematology auto analyzer detect cancer?
Hematology analyzers do not diagnose cancer directly, but they can flag abnormal findings — such as blast cells, abnormal lymphocytes, or unusual WBC distributions — that warrant further investigation. These flags serve as critical screening triggers for hematological malignancies like leukemia and lymphoma.
Q5: What certifications should a hematology auto analyzer have?
Key regulatory certifications to look for include CE (Europe), FDA (United States), ISO 13485:2016 (quality management), and ISO 9001 (general quality standards). Ozelle’s analyzers carry all of these certifications.
Q6: What is the difference between CBC and CBM?
CBC (Complete Blood Count) refers to the standard quantitative analysis of blood cell counts and indices. CBM (Complete Blood Morphology) is an enhanced version that also provides actual microscopic images of blood cells and AI-powered morphological classification, allowing detection of subtle abnormalities like teardrop cells, schistocytes, and immature granulocytes that a standard CBC would miss.
Q7: Are hematology auto analyzers suitable for point-of-care use?
Yes — compact, maintenance-free analyzers like the Ozelle EHBT-50 MiniLab are specifically designed for point-of-care environments including pharmacies, GP clinics, emergency departments, ambulances, and mobile health units. Their cartridge-based design eliminates liquid reagent handling and frequent maintenance.
Q8: How does AI improve hematology analysis?
AI improves hematology analysis by recognizing subtle morphological features that traditional counting methods cannot capture. Neural networks trained on tens of millions of samples can classify rare or abnormal cell types, provide differential diagnosis suggestions, and flag results for clinical review — all automatically and without manual intervention.
Choosing the Right Analyzer for Your Setting
When selecting a hematology auto analyzer, consider the following factors:
- Clinical depth needed: Primary screening vs. specialist diagnostics determines whether a 3-diff or 7-diff system is appropriate
- Sample volume and patient population: Pediatric or elderly patients benefit from fingertip capillary sampling (30 µL)
- Testing environment: High-throughput hospital labs need speed; remote clinics need portability and maintenance-free operation
- Integrated testing needs: If you need immunoassay or biochemistry alongside CBC, an all-in-one platform like the Ozelle EHBT-50 reduces cost and complexity significantly
- Connectivity requirements: IoT-enabled analyzers support remote monitoring, LIS/HIS integration, and data-driven management across multi-site networks
As AI continues to mature and training datasets grow, the gap between point-of-care hematology analyzers and central laboratory reference systems will continue to narrow — making expert-level blood diagnostics available to more patients, in more places, at lower cost than ever before.